Research

In a recent study, George Mason University Associate Professor Hong Xue, PhD and colleagues evaluated the impact of ending market exclusivity for brand-name statin drugs. The first study to comprehensively assess the economic impact of generic competition for statins found that ending market exclusivity for statins saves U.S. $12 billion and individuals nearly $1,000 annually.

Accelerate 2022, held on Mason’s Arlington Campus on Oct. 19-20, focused on showcasing up-and-coming startups throughout the greater Washington, D.C., region.

The National Science Foundation (NSF)’s I-Corps program is an accelerator that helps entrepreneurs and researchers work together “to bring invention to impact.” Mason serves as an official I-Corps site, supporting local grantees through the exploratory stages of venture-building, as well as preparing them to apply for the national-level program.

A new national survey of U.S. nonprofits shows scale of diversity and the effects of the pandemic on donation trends.

The Washington Center for Equitable Growth is awarding $80,000 to help George Mason University professor Bweikia Foster Steen and fellow researchers study home-based childcare providers in Virginia.

With COVID-19 continuing to spread throughout the world, there is a demand for rapid, noninvasive diagnostics. George Mason University researchers Robin Couch and Allyson Dailey, members of the College of Science and the Institute of Biohealth Innovation, are working to answer that call with their research on volatile organic compounds (VOCs) for infectious disease detection.

Mason to collaborate with COMSovereign and Widelity on 5G innovation

Now that most public school districts have resumed in-person instruction, those in health care are beginning to see increases in pediatric admissions due to COVID-19 and other respiratory pathogens and are bracing for surges, according to Amira Albert Roess, professor of global health and epidemiology in George Mason University’s College of Health and Human Services.